1 / 9

Genome Editing Market share to see growth of 14% from 2016 to 2024

Get more details @ http://bit.ly/2tIFyLF <br><br>Major industry participants for the global gene editing market share include Agilent Technologies, Allele Biotech, AstraZeneca, Bio Rad, Cellectis, CRISPR Therapeutics, Editas Medicine, GE Healthcare Dharmacon, Lonza, Qiagen, Recombinetics, Sigma-Aldrich and Thermo Fisher Scientific.

jueekate
Télécharger la présentation

Genome Editing Market share to see growth of 14% from 2016 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Genome Editing Market to grow at 14% CAGR from 2016 to 2024: Fractovia.org

  2. Key Insights ofGenome Editing Market: • Global Market Insights, Inc. says, Genome editing industry value, worth USD 2.17 billion in 2015, is set to hit USD 7.5 billion by 2024. • Genome editing market revenue is anticipated to witness a notable surge over the years ahead, driven by the escalating occurrence of cancer and other genetic inherited disorders coupled with mounting demand for personalized medicines. • Companies have been spending extensively on R&D activities across the pharma & biotech sectors. • Considering the geographical landscape, U.S. genome editing market, worth USD 518.5 million in 2015, is slated to expand considerably in the future. • UK genome editing industry is projected to cross a revenue of USD 744 million by 2024, registering a CAGR of 14.9% over 2016-2024. The high occurrence of chronic disorders among the rising old population will propel the industry development.

  3. Continued… • Japan genome editing market revenue, worth USD 160 million in 2015, is projected to grow at a rate of 15% over the coming timeframe. • Improvement in healthcare amenities and favorable government policies to restrict the spread of infectious diseases will push the business expansion. • Hematology, which contributed USD 807 million towards gene editing industry share in 2015, is expected to make notable contributions towards the industry revenue even in the future. • Biotech & pharma firms, contract research organizations, and research institutes are the key end-users of genome editing industry. • Genome editing makes use of technologies such as meganucleases, CRISPR/Cas9, TALENS, and zinc finger nucleases. CRISPR technology, which dominated the overall market in 2015, is set to surpass USD 3 billion by 2024. • Bio Rad Laboratories Inc., Editas Medicine, Sigma-Aldrich, Thermo Fisher Scientific, and Allele Biotechnology are the major players of gene editing market.

  4. U.S. Gene Editing Market Size, by Application, 2013- 2024 (USD Million)

  5. Browse Full Market Research Report of Genome Editing Market @ http://bit.ly/2tY7J4N Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/499

  6. Table of Contents: Chapter 1. Methodology and Scope 1.1 Research Methodology 1.1.1 Initial data exploration 1.1.2 Statistical modeling and forecast 1.1.3 Industry insights and validation 1.1.4 Research scope and assumptions 1.2 Data Sources 1.2.1 Primary sources 1.2.2 Secondary sources Chapter 2. Executive Summary 2.1 Gene Editing industry 3600 synopsis, 2013 - 2024 2.1.1 Business trends 2.1.2 Application trends 2.1.3 Technology trends 2.1.4 End User trends 2.1.5 Regional trends

  7. Continued… Chapter 3. Gene Editing Industry Insights 3.1 Industry segmentation 3.2 Industry Size and forecast, 2013 – 2024 3.3 Industry ecosystem analysis 3.3.1 Vendor matrix 3.4 Industry Impact forces 3.4.1 Growth drivers 3.4.1.1 Increased funding for genetics research 3.4.1.2 Increased R&D expenditure and growth of biotechnology 3.4.1.3 Increasing demand for synthetic genes 3.4.1.4 Growing use of genetically modified technology 3.4.1.5 Technology advancements 3.4.2 Industry pitfalls & challenges 3.4.2.1 Stringent government regulations 3.4.2.2 Dearth of public awareness

  8. Continued… 3.5 Regulatory trends 3.5.1 U.S. 3.5.2 Europe 3.5.3 China 3.6 Growth potential analysis 3.7 Company market share analysis, 2015 3.7.1 Strategy dashboard 3.8 Porter’s analysis 3.9 PESTEL analysis

  9. Stay In Touch Website: https://www.fractovia.org Social Media:

More Related